NASDAQ: $REPL A New Frontier in Melanoma Therapy The FDA has officially granted accelerated approval to Tudriqev (vusolimogene oderparepvec-wtpg), a significant development for patients battling unresectable or metastatic melanoma. This new treatment is designed to be used in combination with nivolumab, providing a novel therapeutic option for those facing this aggressive form of skin cancer.…